Wachtel Lipton represents Halliburton which is buying Baker Hughes for US$36 . It also acts for Allergan, the subject of Actavis’s US$66b purchase plan. David Katz is one of two Wachtel partners involved in both deals. He said: ‘Both drafts were really ‘middle of the road’. While you often see buyer-friendly or seller-friendly agreements, both were reasonably negotiated documents which allowed people to move more quickly.’

Cleary Gottlieb

Numerous other firms are involved – including Davis Polk, Baker Botts and Cleary Gottlieb Steen & Hamilton. Source: Bloomberg